LRRK2 and Parkinson disease: Even for PD cases with identified genetic causes, PD exhibits clinical and genetic heterogeneity with PD causing mutations including, e.g., PINK1, SNCA, LRRK2 and PARK2. The current intervention strategies are limited to treating symptoms, and no curative treatment is available3.